This study examined the effect of physical activity on long-term prostate cancer survival. Researchers reported a strong link between higher physical activity and increasing survival after prostate cancer diagnosis.

What happens to hormone levels in women (and men) randomized to drink soy milk?

?Below is an approximation of this video’s audio content. To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring, watch the above video.

The vast majority of breast cancers start out “hormone-dependent,” meaning the primary human estrogen, called “estradiol plays a crucial role in [breast cancer] development and progression.” That’s one of the reasons why soy food consumption appears so protective against breast cancer—because soy phytoestrogens, like genistein, act as estrogen-blockers. They block the binding of estrogens, like estradiol, to breast cancer cells.

But, wait a second. “The majority of breast cancers occur [after menopause], when the ovaries have [stopped producing estrogen].” What’s the point of eating estrogen blockers if there’s no estrogen to block? It turns out the breast cancer tumors themselves produce their own estrogen from scratch to fuel their own growth.

Estrogens may be formed in breast tumors by multiple pathways. The breast cancer takes cholesterol, and, using the aromatase enzyme, or two hydroxysteroid dehydrogenase enzymes, produces its own estrogen.

So, there’s two ways to stop breast cancer. One is to use “antiestrogens,” estrogen-blockers, like the soy phytoestrogens, or “the anti-estrogen [drug] tamoxifen…However, another way to block estradiol is by using anti-enzymes” to prevent the breast cancer from making all the estrogen in the first place.

And, indeed, there are a variety of anti-aromatase drugs in current use. In fact, inhibiting the estrogen production has been shown to be “more effective” than just trying to block the effects of the estrogen—”suggesting that the inhibition of estrogen synthesis is clinically very important for the treatment of estrogen-dependent breast cancer.” It turns out soy phytoestrogens can do both.

Using ovary cells taken from women undergoing in vitro fertilization, soy phytoestrogens were found to reduce the expression of the aromatase enzyme. What about in breast cancer cells, though? Breast cancer cells, too—not only suppressing aromatase activity, but the other estrogen-producing enzyme, too.

But, this is in a petri dish. Does soy suppress estrogen production in people too Well, circulating estrogen levels appear significantly lower in Japanese women than American white women. And, Japan does have the highest per capita soy food consumption. But, you don’t know it’s the soy until you put it to the test. Japanese women were randomized to add soymilk to their diet—or not—for a few months. Estrogen levels did seem to drop about a quarter in the soymilk-supplemented group. Interestingly, when they tried the same experiment in men, they got similar results: a significant drop in female hormone levels, with no change in testosterone levels.

These results, though, are in Japanese men and women that were already consuming soy in their baseline diet. So, it’s really just looking at “higher versus lower…soy intake.”

What happens if you give soymilk to women in Texas? Circulating estrogen levels cut in half. Since increased estrogen levels are a “[marker] for high risk for breast cancer,” the effectiveness of soy to reduce estrogen levels may help explain why Chinese and Japanese women have such low rates of breast cancer.

And, what was truly remarkable is that estrogen levels stayed down a month or two, even after they stopped drinking it. This suggests you don’t have to consume soy every day to have the cancer-protective benefit.

This study examined the relationship between stroke survival and the use of statins before and during hospitalization for stroke.

This study investigated the relationship between the use of metformin (Glucophage) and prostate cancer mortality.

This study aimed to evaluate post-traumatic stress disorder (PTSD) in patients who have had treatment for cancer. This study found that a number of patients undergoing cancer treatment developed PTSD after treatment and recommended that supports are put in place. 

This study compared the efficacy of intermittent and continuous androgen deprivation therapy and their affect on quality of life.

This study looked at whether patients should be prescribed antihypertensive medication after stroke. The authors concluded that treatment with antihypertensive medication reduced the risk of death from cardiovascular disease in stroke patients.

This study evaluated the quality of life of long-term breast cancer survivors. 

The authors aimed to determine whether patients who received androgen deprivation therapy were more at risk of experiencing cardiovascular events.

This study investigated the accuracy of the 70-gene signature (MammaPrint) genomic profiling test in predicting metastasis and long-term outcomes among breast cancer patients.